Latham & Watkins Advises Tempus AI in Acquisition of Paige

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, has announced the acquisition of Paige, an AI company specializing in digital pathology. The acquisition allows Tempus to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology with an industry-leading technology portfolio.

Latham & Watkins LLP advised Tempus AI in the transaction with a corporate team led by Chicago/New York partner Bradley Faris and Chicago partner Jana Kovich, with associates Ebenezer Abaidoo and Alexandra Gómez, and assistance from Ryan Baker and Anuj Ezekiel. Advice was also provided on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Zac Alpert; on executive compensation and employee benefits matters by Bay Area partner Ashley Wagner, with associate Julia Lee; on intellectual property matters by New York partner Pelin Serpin, with associate Sebastian Moss; on healthcare regulatory matters by Bay Area partner Betty Pang, with associate Margaret Rote; on FDA regulatory matters by Washington, D.C. partner Liz Richards, with associate Evan Miller; on tax matters by Chicago partner Rene de Vera; and on capital markets matters by Chicago partner Cathy Birkeland, with associate Kenneth Sands.